Budapest, Hungary

Judit Gyorgyi Nee Edelenyi


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Judit Gyorgyi Nee Edelenyi: Innovator in Pharmaceutically Active Copolymers

Introduction

Judit Gyorgyi Nee Edelenyi is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of copolymers with heparin-like activity. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Judit holds a patent for "Pharmaceutically active copolymers, process for their preparation." This invention relates to new, pharmaceutically active copolymers that exhibit heparin-like activity. The copolymers consist of specific units that are arranged in a statistical manner, allowing for the potential replacement of organogenic heparin or providing a synergistic combination with it. This patent highlights her innovative approach to pharmaceutical development and her commitment to improving healthcare solutions. She has 1 patent to her name.

Career Highlights

Throughout her career, Judit has been associated with Richter Gedeon Vegyeszeti Gyar Rt., a leading pharmaceutical company in Hungary. Her work at this esteemed organization has allowed her to focus on research and development in the field of pharmaceuticals, contributing to advancements that benefit patients and healthcare providers alike.

Collaborations

Judit has collaborated with notable colleagues, including Raymund Machovich and Miklos Nagy. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of her work in the pharmaceutical industry.

Conclusion

Judit Gyorgyi Nee Edelenyi is a remarkable inventor whose contributions to the field of pharmaceutically active copolymers have the potential to transform medical treatments. Her dedication to innovation and collaboration underscores her importance in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…